Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients.
Tobias JD, Simsic JM, Weinstein S, Schechter W, Kartha V, Michler R
J Intensive Care Med 2004;19(5):270-273.
Review by
Neonatal alloimmune thrombocytopenia.
Rayment R, Birchall J, Yarranton H, et al.
BMJ 2003;327:331-332.
Review by
Use of perflubron emulsion to decrease allogeneic blood transfusion in high-blood-loss non-cardiac surgery: results of a European phase 3 study.
Spahn DR, Waschke KF, Standl T, et al.
Anesthesiology 2002;97(6):1338-1349.
Review by
Synthetic factor VIIa concentrate to treat coagulopathy and gastrointestinal bleeding in an infant with end-stage liver disease.
Tobias JD, Berkenbosch JW
Clin Pediatr (Phila) 2002;41(8):613-616.
Review by Aldouri M
Recombinant factor VIIa in the management of surgery and acute bleeding episodes in children with haemophilia and high responding inhibitors.
O’Connell N, McMahon C, Smith J, et al.
Br J Haematol 2002;116(3):632-635.
Review by Aldouri M
NATA: Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and other healthcare professionals.
Sitemap
Contact us
- secretary@nataonline.com
-
NATA
Rue de l’Industrie 24
1040 Bruxelles - VAT: 0781668659